A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks
Manuscript Number:
14-1626R2
Author(s):
Craig S. Atwood, Richard L. Bowen, George Perry, Mark A. Smith, Chengjie Xiong
Disclosures
Craig S. Atwood
Nothing to Disclose
Richard L. Bowen
Equity:
Own stock in and was employed by Voyager Pharmaceutical Corp. which sponsored the study but has since filed for bankruptcy and is no longer in business.